English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 1 February 2018, 10:00 HKT/SGT
Share:
    

Source: MIMS Singapore
MIMS Announces Growth, Expansion to New Office in Taiwan

SINGAPORE, Feb 1, 2018 - (Media OutReach) - MIMS, a leading multichannel provider of drug information, medical communications and technology solutions in Asia Pacific, is pleased to announce the opening of a new branch office in Taiwan located at 20th floor, No.97, SEC.2, Dun Hua S. Rd., Taipei, Taiwan.

The latest expansion meets growing demand in Taiwan for medical communications services in the healthcare industry. The new Taiwan branch has a professional team of members from both Taiwan and Hong Kong delivering medical communications solutions catering to the Taiwan market, with a regional perspective and through a multidisciplinary and integrated approach.

"MIMS brings to Taiwan deep expertise in medical communications and strategy," stated Victor Wright, Regional VP of Medical Communications APAC. "MIMS takes pride in bringing exceptional scientific content and events management along with rigorous editorial standards and strict regulatory compliance. It's an exciting opportunity for MIMS to provide best-in-class solutions to the Taiwan pharmaceutical industry."

Prior to the official opening in Taipei, MIMS has offered these services to several multinational pharmaceutical companies in Taiwan.

MIMS has a leading position in the Asia-Pacific healthcare landscape, anchored in its drug reference publications historically. In the past decade, it has evolved to develop progressive digital solutions to empower doctors and healthcare communities to improve patient outcomes.

About MIMS Group

Established in 1963, MIMS is a multichannel provider of drug information, medical education and digital solutions connecting healthcare communities. Our work empowers healthcare communities to improve patient outcomes by facilitating knowledge exchange and better decision-making. Today, MIMS is present in 13 countries (including Taiwan) across Asia Pacific region with approximately two million healthcare professional subscribers to its drug & resource portal, digital and print publications.

Contact:
MIMS Taiwan office address is 20th floor., No. 97, SEC. 2, Dun Hua S. Rd., Taipei, Taiwan. Telephone number: +886 (02) 2709 0611

For more information about the MIMS Taiwan office, please contact Victor Wright at +852 6463-1177, victor.wright@mims.com.

Topic: Press release summary
Source: MIMS Singapore


https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
JBM Healthcare Issues Positive Profit Alert  
May 5, 2024 11:00 HKT/SGT
Aemetis to Review First Quarter 2024 Financial Results on May 9, 2024  
May 4, 2024 01:00 HKT/SGT
Peapack Private Hires Jerry Dominguez as Senior Managing Director  
May 4, 2024 01:00 HKT/SGT
UVify Sets New Guinness World Record With 5,293 IFO Drones in Spectacular Aerial Display  
May 4, 2024 00:00 HKT/SGT
2024 CAP Consumer Survey Shows Increase in Piracy on Social Media and Messaging Platforms in Asia Pacific  
May 3, 2024 20:40 HKT/SGT
SDAI Limited: Positive Outcomes Since New Board took over in June 2023  
May 3, 2024 20:00 HKT/SGT
Loop Industries and Ester Industries Ltd. Announce Joint Venture Agreement to Build an Infinite Loop(TM) Manufacturing Facility in India  
May 3, 2024 20:00 HKT/SGT
Singapore's top general insurer debuts trading on Asia's leading digital exchange, AltaX   
May 3, 2024 10:30 HKT/SGT
Nephros Schedules First Quarter 2024 Financial Results Conference Call  
May 3, 2024 08:31 HKT/SGT
Nass Valley Gateway Ltd Announces It Will File Its 2023 EOY Audited Financials by June 28th, 2024, Within the Extension Granted by the BCSC  
May 3, 2024 08:26 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575